The Breast
Volume 19, Issue 4 , Pages 289-296 , August 2010

The relationship between quality and cost during the perioperative breast cancer episode of care

  • Jeffrey Landercasper

      Affiliations

    • Norma J. Vinger Center for Breast Care, Gundersen Lutheran Health System, 1900 South Avenue, La Crosse WI 54601, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 608 775 5695; fax: +1 608 775 6569.
    • Co-Chairman, Patient Safety and Quality Committee of the American Society of Breast Surgeons.
    • ,
  • Lorraine Tafra

      Affiliations

    • AAMC Breast Center, Anne Arundel Medical Center, 2001 Medical Parkway, Annapolis, MD 21401, USA
    • Chairman, Patient Safety and Quality Committee of the American Society of Breast Surgeons.

References 

  1. Committee on Quality of Health Care in America, Institute of Medicine. In:  Kohn LT,  Corrigan JM,  Donaldson MS editor. To err is human. Washington, DC: National Academy Press; 2000;
  2. Institute of Medicine Committee on Quality of Health Care in America. In: Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001;
  3. Improving healthcare quality. Available from: http://www.qualityforum.org/setting_priorities/improving_healthcare_quality.aspx [accessed February 19, 2010].
  4. Edge S. Finding and achieving value in cancer care. Panel discussion. In:  Callan Kimberley,  Lynch Conor editor. Highlights of the NCCN 14th annual conference. NY 11724: Cold Springs Publishing. Cold Spring Harbour; March 11, 2009;Available from: http://www.nccn.org/interactive/video/14thannual/roundtable2.aspp. 14 [accessed February 19, 2010]
  5. Newcomer L. Finding and achieving value in cancer care. Panel discussion. In:  Callan Kimberley,  Lynch Conor editor. Highlights of the NCCN 14th annual conference. NY 11724: Cold Springs Publishing. Cold Spring Harbour; March 11, 2009;Available from: http://www.nccn.org/interactive/video/14thannual/roundtable2.aspp. 14 [accessed February 19, 2010]
  6. Evans WK, Brouwers MC, Bell CM. Commentary: Should cost of care be considered in clinical practice guidelines?. J Natl Compr Canc Netw. 2008;6:224–226
  7. Kolb GR. Disease management is the future. Breast cancer is the model. Surg Onc Clinics NA. 2000;9:217–232
  8. Burley C. Chartered value exchanges. Bull Am Coll Surg. 2008;93:8–10
  9. National comprehensive cancer network guidelines for diagnosis and treatment of breast cancer. Available from: http://www.nccn.org [accessed Nov 1, 2009].
  10. National Accreditation Program for Breast Centers. Available from: http://accreditedbreastcenters.org/standards/standards.html [accessed Nov 1, 2009].
  11. Quality measures. Available from: http://www.qualitymeasures.ahrq.gov [accessed February 19, 2010].
  12. European Society of Breast Cancer Specialists. Available from: http://www.eusoma.org [accessed February 19, 2010].
  13. National Consortium of Breast Centers. Available from: http://www.breastcare.org [accessed Nov 1, 2009].
  14. American Society of Breast Surgeons. Available from: http://www.breastsurgeons.org [accessed Nov 1, 2009].
  15. Brucker SY, Schumacher C, Sohn C, Rezai M, Bamberg M, Wallweiner D. Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003–2007) from Germany as a proof of concept. BMC Cancer. 2008;8:358
  16. Harnet A, Smallwood J, Titshall V, Champion A. Diagnosis and treatment of early breast cancer, including locally advanced disease – summary of NICE guidance. BMJ. 2009;338:598–600
  17. Blarney R, Cataliotti L. The requirements of a specialized breast unit. EUSOMA position paper. Available from: http://www.eusoma.org [accessed February 19, 2010].
  18. NIH State-of-the-Science Consensus Conference. Diagnosis and management of ductal carcinoma in situ. Available from: http://www.consensus.nih.gov/2009/dcisstatement.htm [accessed on 11/1/09].
  19. Silverstein MJ, Recht A, Lagios MD, et al. Image detected breast cancer: State-of-the-art diagnosis and treatment. J Am Coll Surg. 2009;209:504–519
  20. The Surgical Compass Report. Available from: http://www.advisoryboardcompany.com/content/bi/surgery_compass.html [accessed February 19, 2010].
  21. Quality measure glossary. . Available from: http://www.qualitymeasures.ahrq.gov/resources/glossary.aspx [accessed February 19, 2010].
  22. Sarvazyan A, Egorov V, Son JS, Kaufman CS. Cost-effectiveness screening for breast cancer worldwide: current state and future directions. Breast Cancer. 2008;1:91–99
  23. Liberman L, Samo MP. Cost effectiveness of stereotactic 11 gauge directional vacuum assisted biopsies. Am J Roentgenol. 2000;175:53–58
  24. Cancer facts and figures. American Cancer Society; May 1, 2009;Available from: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf
  25. McCahill LE, Privette A, James T, et al. Quality measures for breast cancer surgery: Initial validation of feasibility and assessment variation among surgeons. Arch Surg. 2009;144:455–462
  26. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888–897
  27. NCCN oncology trends report. managed care and medical oncology: “Cancer is now on the table”. NCCN oncology trends. report 1; 2009. NCCN. 275 Commerce Drive, Fort Washington, PA. Tel.: +1 215 690 0300.
  28. Campbell JD, Ramsey SD. The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics. 2009;27:199–209
  29. Waterbury M. Oncology reimbursement: managed care challenges and considerations. Managed Care Oncology. 2006;Spring:13–15
  30. Bickel NA, Mendez J, Guth AA. The quality of early-stage breast cancer treatment: what can we do to improve?. Surg Oncol Clin N Am. 2005;14:103–117
  31. Malin JL, Schuster MA, Kahn KA, Brook RH. Quality of breast cancer care: what do we know?. J Clin Oncol. 2002;20:4381–4393
  32. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the national initiative for cancer care quality: how can we improve the quality of cancer care in the United States?. J Clin Oncol. 2006;24:626–634
  33. Lash TL, Silliman RA, Guadagnoli E, Mor V. The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer. 2000;89:1739–1747
  34. Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol. 2004;22:3685–3693
  35. Bloom BS, de Pouvourville N, Chhatre S, Jayadevappa R, Weinberg D. Breast cancer treatment in clinical practice compared to best evidence and practice guidelines. Br J Cancer. 2004;90:26–30
  36. Coburn N, Fulton J, Pearlman DN, Law C, DiPaolo B, Cady B. Treatment variation by insurance status for breast cancer patients. Breast J. 2008;14:128–134
  37. Griggs JJ, Sorbero ME, Ahrendt GM, et al. The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatment. Med Care. 2009;47:749–757
  38. Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in surveillance, epidemiology, and end results – Medicare data. Cancer. 2009;115:716–724
  39. Mayor S. News: NICE recommends kidney cancer drug it previously rejected on cost grounds. BMJ. 2009;338:499
  40. Opelka F, Lewis J. Transformational change in health care: Identifying the current state and future state. Bull Am Coll Surg. 2008;93:15–21
  41. Kuttner R. Market based failure – a second opinion on the US health care cost. N Eng J Med. 2008;358:549–551
  42. Bruening W, Schoelles K, Treadwell J, et al. Comparative effectiveness of core-needle and open surgical biopsy for the diagnosis of breast lesions. Prepared by ECRI Institute Evidence-based Practice Center under contract no. 290-02-0019 Comparative effectiveness review no. 19. Rockville, MD: Agency for Healthcare Research and Quality; December 2009;http://www.effectivehealthcare.ahrq.gov/reports/final.cfm[accessed Dec 15, 2009]
  43. Lee DW, Stang PE, Goldberg GA, Haberman M. Resource use and cost of diagnostic workup of women with suspected breast cancer. Breast J. 2009;15:85–92
  44. Golub RM, Bennett CL, Stinson T, Venta L, Morrow M. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. 2004;22:2430–2437
  45. Gruber R, Bernt R, Helbich TH. Cost-effectiveness of percutaneous core needle breast biopsy (CNBB) versus open surgical biopsy (OSB) of nonpalpable breast lesions: metaanalysis and cost evaluation for German-speaking countries. Rofo. 2008;180:134–142
  46. Pocock B, Taback B, Klein L, Joseph KA, El-Tamer M. Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol. 2009;16:1108–1111
  47. Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, van Dam GM. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol. 2009;16:2717–2730
  48. Rutgers EJ. Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol. 2005;31:568–576
  49. Genta F, Zanon E, Camanni M, et al. Cost/accuracy analysis in breast cancer patients undergoing ultrasound guided fine-needle aspiration cytology, sentinel lymph node biopsy, and frozen section of node. World J Surg. 2007;31:1155–1163
  50. Cody HS. One step surgery for breast cancer: back to the future?. World J Surg. 2007;1153–1154
  51. Chan SW, LaVigne KA, Port ER, et al. Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?. Ann Surg. 2008;247:143–149
  52. McLaughlin SA, Ochoa-Frongia LM, Patil SM, Cody HS, Scalfini LM. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. J Am Coll Surg. 2008;206:76–82
  53. Vanderveen KA, Ramsamooj R, Bold RJ. A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol. 2008;15:2006–2011
  54. Cipolla C, Cabibi D, Fricano S, Viena S, Gentile I, Latteri MA. The value of intraoperative frozen section examination of sentinel lymph nodes in surgical management of breast carcinoma. Langenbecks Arch Surg [Epub ahead of print].
  55. Krishnamurthy S, Meric-Bernstam F, Lucci A, et al. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer. 2009;115:1555–1562
  56. van de Vrande S, Meijer J, Rijnders A, Klinkenbijl JH. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer. Eur J Surg Oncol. 2009;35:276–280
  57. Schwartz GF, Krill LS, Palazzo JP, Dasgupta A. Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breast. J Am Coll Surg. 2008;207:758–762
  58. El-Tamer MB, Ward BM, Schiffner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245:672–673
  59. Boughey JC, Goravanchi F, Parris RN, et al. Improved postoperative pain control using thoracic paravertebral block for breast operations. Breast J. 2009;15:483–488
  60. Kitowski NJ, Landercasper J, Gundrum JD, et al. Local and paravertebral block anesthesia for outpatient elective breast cancer surgery. Arch Surg; in press.
  61. Neumayer L, Shifftner TL, Henderson WG, Khuri S, El-Tamer M. Breast cancer surgery in Veteran’s Affairs and selected university medical centers: results of patient safety in surgery study. J Am Coll Surg. 2007;204:1235–1241
  62. Rose C, Stovall E, Ganz PA, Desch C, Hewitt M Cancer Quality Alliance. Blueprint for a better cancer care system. CA Cancer J Clin. 2008;58:266–292
  63. Health costs, quality and outcomes research. US Department of Health and Human Services. Available from: http://www.hhs.gov/asrt/ob/docbudget/2010budgetinbriefj.html [accessed February 19, 2010].
  64. Grants and calls for proposals. Robert Wood Johnson Foundation. Available from: http://www.rwjf.org/grants/Last [accessed February 19, 2010].
  65. Hassett MJ, Hughes ME, Niland JC, et al. Selecting high priority quality measures for breast cancer quality improvement. Med Care. 2008;46:762–770
  66. Brooke RH. The Rand/UCLA appropriateness method. Clinical Practice Guideline Development: methodology perspectives. Rockville (MD): Public Health Service AHCR; 1994;
  67. McGory ML, Shekelle PG, Cy Ko. Development of quality indicators for patients undergoing colorectal surgery. J Natl Cancer Inst. 2006;98:1623–1633
  68. Preamble to the Constitution of the World Health Organization . In: World Health Organization  editors. Interim Commission of the World Health Organization. Official records of the World Health Organization. vol. 2:New York,; Geneva: United Nations; World Health Organization; Interim Commission; 1947;p. 100
  69. Chirikos TN, French DD, Luther SL. Potential economic effects of volume-outcome relationships in the treatment of three common cancers. Cancer Control. 2004;11:258–264
  70. Smith BD, Smith GL, Roberts KB, Buchholz TA. Baseline utilization of breast radiotherapy before institution of the Medicare practice quality reporting initiative. Int J Radiat Oncol Biol Phys. 2009;74:1506–1512
  71. Physician’s quality reporting initiative. Available from: http://www.cms.hhs.gov/pqri [accessed February 19, 2010].
  72. Punglia RS, Hughes ME, Edge SB, et al. Factors associated with guideline-concordant use of radiotherapy after mastectomy in the National Comprehensive Cancer Network. Int J Radiat Oncol Biol Phys. 2008;72:1434–1440
  73. Buccholz TA, Theriault RL, Niland JC, et al. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006;24:361–369
  74. Lee BT, Tobias AM, Yueh JH, et al. Design and impact of an intraoperative pathway: a new operating room model for team-based best practice. J Am Coll Surg. 2008;207:865–873
  75. Fung-Kee-Fung M, Watters J, Crossley C, et al. Regional collaborations as a tool for quality improvements in surgery: a systemic review of the literature. Ann Surg. 2009;249:565–572
  76. Institute for Healthcare Improvement. The triple aim. Available from: http://www.ihi.org/IHI/Programs/StrategicInitiatives/TripleAim.htm [accessed February 19, 2010].
  77. Kaufman CS, Shockney L, Rabinowitz B, et al. National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17:377–385
  78. Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VJ. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143:53–60

PII: S0960-9776(10)00068-8

doi: 10.1016/j.breast.2010.03.014

The Breast
Volume 19, Issue 4 , Pages 289-296 , August 2010

Article Tools